Related Experiment Video
Updated: Jul 11, 2026

In Vitro Assay to Evaluate the Impact of Immunoregulatory Pathways on HIV-specific CD4 T Cell Effector Function
Published on: October 15, 2013
The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells
Karin Mausner-Fainberg1, Galia Luboshits, Adi Mor
1The Department of Cardiology, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Insights
Statins, widely used for lowering LDL cholesterol, may improve cardiovascular outcomes by boosting regulatory T cells (Tregs). Atorvastatin specifically increased functional Tregs in human blood, suggesting a novel immune mechanism for statin benefits.
Area of Science:
- Immunology
- Pharmacology
- Cardiovascular Medicine
Background:
- Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are widely prescribed for their lipid-lowering effects and cardiovascular benefits.
- Immune-mediated mechanisms are increasingly recognized as crucial to the therapeutic actions of statins, particularly in atherosclerosis.
- CD4(+)CD25(+) regulatory T cells (Tregs) are vital for immune homeostasis, suppressing excessive immune responses and preventing inflammatory diseases.
Purpose of the Study:
- To investigate the hypothesis that statins modulate the number and functional capacity of circulating regulatory T cells (Tregs).
- To explore potential immune-based mechanisms underlying the clinical benefits of statin therapy.
Main Methods:
- Human peripheral blood mononuclear cells (PBMCs) and murine cells were treated in vitro and in vivo with various statins (atorvastatin, mevastatin, pravastatin, simvastatin).
- Flow cytometry was used to quantify Tregs (CD4(+)CD25(+)Foxp3(+)) and assess Foxp3 expression levels.
- Co-culture experiments were performed to determine the origin of statin-induced Tregs.
Main Results:
- In vitro treatment of human PBMCs with atorvastatin significantly increased the number of CD4(+)CD25(high) and CD4(+)CD25(+)Foxp3(+) Tregs.
- Atorvastatin-induced Tregs exhibited enhanced regulatory function, with Foxp3 expression levels correlating positively with regulatory potential.
- Simvastatin and pravastatin increased Treg numbers in hyperlipidemic human subjects, while statin treatment showed no effect on Tregs in C57BL/6 mice.
Conclusions:
- Statins, particularly atorvastatin, can significantly expand the peripheral pool of functional Tregs in humans.
- This statin-induced modulation of Tregs may represent a key mechanism contributing to their plaque-stabilizing and anti-inflammatory effects.
- The observed effects on Tregs appear to be species-specific, with no significant impact noted in mice.
Abstract:
Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are in widespread use due to their LDL reducing properties and concomitant improvement of clinical outcome in patients with and without preexisting atherosclerosis. Considerable evidence suggests that immune mediated mechanisms play a dominant role in the beneficial effects of statins. Naturally occurring CD4(+)CD25(+) regulatory T cells (Tregs) have a key role in the prevention of various inflammatory and autoimmune disorders by suppressing immune responses. We tested the hypothesis that statins influence the circulating number and the functional properties of Tregs. We studied the effects of in vivo and in vitro statin treatment of human and murine mononuclear cells on the number of Tregs and the expression level of their master transcription regulator, Foxp3. Atorvastatin, but not mevastatin nor pravastatin, treatment of human peripheral blood mononuclear cells (PBMCs) increased the number of CD4(+)CD25(high) cells, and CD4(+)CD25(+)Foxp3(+) cells. These Tregs, induced by atorvastatin, expressed high levels of Foxp3, which correlated with an increased regulatory potential. Furthermore, co-culture studies revealed that atorvastatin induced CD4(+)CD25(+)Foxp3(+) Tregs were derived from peripheral CD4(+)CD25(-)Foxp3(-) cells. Simvastatin and pravastatin treatment in hyperlipidemic subjects increased the number of Tregs. In C57BL/6 mice however, no effect of statins on Tregs was evident. In conclusion, statins appear to significantly influence the peripheral pool of Tregs in humans. This finding may shed light on the mechanisms governing the plaque stabilizing properties of statins.
More Related Videos
07:17Phenotypic and Functional Analysis of Activated Regulatory T Cells Isolated from Chronic Lymphocytic Choriomeningitis Virus-infected Mice
Published on: June 22, 2016
12:07Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays
Published on: March 14, 2011
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...